发明名称 Antibodies against the RGM A protein and uses thereof
摘要 The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind and neutralize RGM A protein. Specifically, these antibodies have the ability to inhibit the binding of RGM A to its receptor and/or coreceptors. These antibodies or portions thereof of the invention are useful for detecting RGM A and for inhibiting RGM A activity, for example in a human suffering from a disorder including but nor limited to multiple sclerosis, mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.
申请公布号 US8962803(B2) 申请公布日期 2015.02.24
申请号 US200912389927 申请日期 2009.02.20
申请人 AbbVie Deutschland GmbH & Co. KG;AbbVie Inc. 发明人 Mueller Bernhard K.;Schmidt Martin;Barlow Eve;Leddy Mary;Hsieh Chung-Ming;Bardwell Philip
分类号 C07K16/00 主分类号 C07K16/00
代理机构 Michael Best & Friedrich LLP 代理人 Mueller Lisa V.;Michael Best & Friedrich LLP
主权项 1. An isolated antibody comprising an antigen binding domain, said antibody capable of binding an epitope of a RGM molecule, said antigen binding domain comprising a heavy chain variable domain having three complementary determining regions and a light chain variable domain having three complementary determining regions, wherein the three complementary determining regions of the heavy chain variable domain have the amino acid sequence of SEQ ID NO:57, SEQ ID NO:58 and SEQ ID NO:59 and the three complementary determining regions of the light chain variable domain have the amino acid sequence of SEQ ID NO: 60, SEQ ID NO:61 and SEQ ID NO:62.
地址 Wiesbaden DE